Amgen
$403.04Change from previous close: −1.04%Absolute change: −$4.23
At a glance
- Revenue growth
- +9.95%
- 2025 vs 2024
- Net income growth
- +88.53%
- 2025 vs 2024
- Net margin
- 21.0%
- 2024: 12.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4,002 | 2,189 | 1,603 | 4,684 | 2,280 | 1,391 | 4,771 | 3,571 | 2,459 | 689 | 538 | 2,760 |
| Depreciation and amortization | 1,112 | 1,116 | 1,132 | 1,307 | 1,341 | 1,387 | 1,397 | 1,396 | 1,400 | 1,399 | 1,380 | 895 |
| Capital expenditure | -513 | -712 | -642 | -436 | -369 | -411 | -371 | -257 | -238 | -230 | -249 | -248 |
| Investing cash flow | -569 | -716 | -693 | -414 | -389 | -447 | -402 | -210 | -217 | -217 | -27,089 | -262 |
| Financing cash flow | -1,482 | 1,436 | -1,226 | -2,853 | -2,673 | -4,107 | -1,407 | -3,651 | -2,649 | -1,708 | 2,754 | -2,005 |
| Dividends paid | -1,362 | -1,358 | -1,283 | -1,282 | -1,280 | -1,279 | -1,205 | -1,210 | -1,209 | -1,208 | -1,140 | -1,140 |
| Share repurchases | — | — | — | — | — | — | -200 | — | — | — | — | — |
| Debt issued | 0.0 | 3,964 | — | — | 0.0 | 0.0 | — | — | — | — | 3,996 | 1.0 |
| Debt repaid | 0.0 | -1,066 | 0.0 | -1,581 | -1,301 | -2,801 | 0.0 | -2,449 | -1,400 | -410 | -97.0 | -880 |
| Net change in cash | 1,951 | 2,909 | -316 | 1,417 | -782 | -3,163 | 2,962 | -290 | -407 | -1,236 | -23,797 | 493 |
| Free cash flow | 3,489 | 1,477 | 961 | 4,248 | 1,911 | 980 | 4,400 | 3,314 | 2,221 | 459 | 289 | 2,512 |
| Levered free cash flow | 1,416 | 1,143 | 1,465 | 4,355 | 215 | 1,208 | 5,371 | 3,276 | 2,913 | 1,844 | -2,295 | 1,336 |